Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$210.76 - $249.51 $6.63 Million - $7.84 Million
-31,436 Reduced 77.3%
9,230 $2.12 Million
Q4 2023

Oct 21, 2024

BUY
$214.88 - $256.94 $8.5 Million - $10.2 Million
39,556 Added 3563.6%
40,666 $8.94 Million
Q4 2023

Feb 07, 2024

BUY
$214.88 - $256.94 $8.5 Million - $10.2 Million
39,556 Added 3563.6%
40,666 $8.94 Million
Q3 2023

Oct 21, 2024

SELL
$211.82 - $248.24 $86,210 - $101,033
-407 Reduced 26.83%
1,110 $250,000
Q3 2023

Nov 07, 2023

BUY
$211.82 - $248.24 $235,120 - $275,546
1,110 New
1,110 $250,000
Q1 2023

Oct 21, 2024

BUY
$212.99 - $276.17 $323,105 - $418,949
1,517 New
1,517 $339,000
Q1 2023

May 03, 2023

SELL
$212.99 - $276.17 $12,140 - $15,741
-57 Reduced 3.62%
1,517 $339,000
Q4 2022

Feb 13, 2023

BUY
$205.95 - $280.43 $324,165 - $441,396
1,574 New
1,574 $437,000
Q2 2022

Aug 09, 2022

SELL
$174.81 - $241.14 $84,608 - $116,711
-484 Reduced 20.17%
1,916 $451,000
Q1 2022

May 12, 2022

BUY
$166.16 - $213.96 $37,718 - $48,568
227 Added 10.45%
2,400 $431,000
Q4 2021

Feb 10, 2022

SELL
$184.32 - $216.08 $2.7 Million - $3.17 Million
-14,659 Reduced 87.09%
2,173 $470,000
Q3 2021

Nov 12, 2021

BUY
$179.86 - $214.88 $2.07 Million - $2.48 Million
11,532 Added 217.58%
16,832 $3.11 Million
Q2 2021

Aug 13, 2021

BUY
$170.47 - $211.93 $426,175 - $529,825
2,500 Added 89.29%
5,300 $951,000
Q1 2021

May 17, 2021

BUY
$153.94 - $174.85 $431,032 - $489,580
2,800 New
2,800 $468,000
Q4 2020

Feb 12, 2021

SELL
$101.87 - $151.79 $278,512 - $414,993
-2,734 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$99.9 - $121.13 $273,126 - $331,169
2,734 New
2,734 $276,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.